XML 32 R21.htm IDEA: XBRL DOCUMENT v3.5.0.2
Earnings per Share
6 Months Ended
Jun. 30, 2016
Earnings Per Share [Abstract]  
Earnings per Share
Earnings per Share
The Company has unvested shares of restricted stock and restricted stock units outstanding that are considered participating securities and, therefore, computes basic and diluted earnings per share under the two-class method. Basic earnings per share for the periods are based upon the weighted average number of shares of common stock outstanding during the periods. Diluted earnings per share include the effect of certain stock options.
 
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
 
2016
 
2015
 
2016
 
2015
Net income attributable to
   Westlake Chemical Corporation
 
$
111,124

 
$
205,095

 
$
234,252

 
$
351,437

Less:
 
 
 
 
 
 
 
 
Net income attributable to participating securities
 
(504
)
 
(253
)
 
(1,054
)
 
(457
)
Net income attributable to common shareholders
 
$
110,620

 
$
204,842

 
$
233,198

 
$
350,980


The following table reconciles the denominator for the basic and diluted earnings per share computations shown in the consolidated statements of operations:
 
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
 
2016
 
2015
 
2016
 
2015
Weighted average common shares—basic
 
129,583,224

 
132,538,123

 
129,886,594

 
132,625,857

Plus incremental shares from:
 
 
 
 
 
 
 
 
Assumed exercise of options
 
397,303

 
506,852

 
403,927

 
498,840

Weighted average common shares—diluted
 
129,980,527

 
133,044,975

 
130,290,521

 
133,124,697

 
 
 
 
 
 
 
 
 
Earnings per common share attributable to
   Westlake Chemical Corporation:
 
 
 
 
 
 
 
 
Basic
 
$
0.85

 
$
1.55

 
$
1.80

 
$
2.65

Diluted
 
$
0.85

 
$
1.54

 
$
1.79

 
$
2.64


Excluded from the computation of diluted earnings per share are options to purchase 695,040 and 330,315 shares of common stock for the three months ended June 30, 2016 and 2015, respectively, and 625,494 and 285,933 shares of common stock for the six months ended June 30, 2016 and 2015, respectively. These options were outstanding during the periods reported but were excluded because the effect of including them would have been antidilutive.